Citation Impact
Citing Papers
Incidence of inflammatory bowel disease in northern France (1988-1990).
1994
Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan
2003 StandoutScience
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2005
Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2
2003 Standout
Hepatocellular carcinoma
2003 Standout
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection
2003 Standout
Management of Crohn's disease in adults
2001
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Ulcerative Colitis
2011 Standout
Clustering in time of familial IBD separates ulcerative colitis from Crohnʼs disease
2009
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm
1994
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study
2001
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease
2002
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2001 StandoutNature
Inflammatory bowel disease: cause and immunobiology
2007 Standout
The interface between innate and adaptive immunity
2004 StandoutNobel
Inflammatory Bowel Disease
2009 Standout
Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population-based cohort followed for ten years
2008
A new prognostic classification for predicting survival in patients with hepatocellular carcinoma
1999
Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends
2010
Management of Hepatocellular Carcinoma *
2005 Standout
CARD15/NOD2 Mutational Analysis and Genotype-Phenotype Correlation in 612 Patients with Inflammatory Bowel Disease
2002
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
2001 StandoutNature
Ulcerative colitis
2012 Standout
Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure
2003
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Plant pathogens and integrated defence responses to infection
2001 StandoutNature
Epidemiology of inflammatory bowel disease
2002
Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis
1999
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
The Importance of Race and Ethnic Background in Biomedical Research and Clinical Practice
2003 Standout
Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics
2003
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Smoking and inflammatory bowel disease
2007
Ulcerative colitis
2016 Standout
A Genomewide Analysis Provides Evidence for Novel Linkages in Inflammatory Bowel Disease in a Large European Cohort
1999
Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity
2000
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16
1998
Family and twin studies in inflammatory bowel disease
2006
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
2012
The Inflammasomes
2010 Standout
Role of genetic and environmental factors in British twins with inflammatory bowel disease
2011
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
The molecular classification of the clinical manifestations of Crohn's disease
2002
The Genetics of Inflammatory Bowel Disease
2007
XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
2008 Standout
Points of control in inflammation
2002 StandoutNature
Stressful Life Events as a Risk Factor for Inflammatory Bowel Disease Onset: A Population-Based Case–Control Study
2006
Autoimmunity and Apoptosis
2001 StandoutNobel
IBD: a family affair
2004
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome
2001 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis
2011
Guidelines for the management of inflammatory bowel disease in adults
2004
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Mapping of inflammatory bowel disease in northern France: Spatial variations and relation to affluence
2009
Toll-Like Receptors
2003 Standout
Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease
2002
Maintenance Therapy in Crohn's Disease
2000
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
2005 StandoutScience
Concordance of Inflammatory Bowel Disease among Danish Twins: Results of a Nationwide Study
2000
Clinical microbiology of coryneform bacteria
1997 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Traditional corticosteroids for induction of remission in Crohn's disease
2008
GENETIC ANALYSIS OF HOST RESISTANCE: Toll-Like Receptor Signaling and Immunity at Large
2006 StandoutNobel
Innate Immune Recognition
2002 Standout
The Structure of Haplotype Blocks in the Human Genome
2002 StandoutScience
Works of Dupas Jl being referenced
Mesalamine in Crohn's disease with steroid-induced remission: Effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives
1996
Clinical characteristics of Crohn's disease in 72 families
1996
[Prognostic factors of hepatocellular carcinoma. Multifactorial analysis of 84 cases].
1993
[Corynebacterium xerosis endocarditis associated with alcoholic cirrhosis].
1996
[What is the prognosis in unclassified colitis? Results of a cohort study of 104 patients in the Northern-Pas-de-Calais region].
1993
[Incidence of inflammatory bowel disease in the Nord-Pas-de-Calais region and the Somme area of France in 1988].
1990
[Familial rectocolonic polyposis, Gardner's syndrome and thyroid cancer : study of 2 cases].
1982